Compile Data Set for Download or QSAR
maximum 50k data
Found 9 of ic50 for UniProtKB: P12590
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611021(US10626108, Compound 15)
Affinity DataIC50:  0.200nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611015(US10626108, Compound 13)
Affinity DataIC50:  1nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611022(US10626108, Compound 21)
Affinity DataIC50:  1nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611029(US10626108, Compound 29)
Affinity DataIC50:  2nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611020(US10626108, Compound 14)
Affinity DataIC50:  2nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611056(US10626108, Compound 36)
Affinity DataIC50:  7nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611028(US10626108, Compound 28)
Affinity DataIC50:  8nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611026(US10626108, Compound 25)
Affinity DataIC50:  26nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHemagglutinin()
Janssen Sciences Ireland Uc

US Patent
LigandPNGBDBM611014(US10626108, Compound 6)
Affinity DataIC50:  130nMAssay Description:The in vitro antiviral activity of the compounds was determined using a cell-based antiviral assay. In this assay, the cytopathic effect (CPE) in Mad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent